{
  "trial_id": "NCT03100877",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "partial response",
      "label": "met"
    },
    {
      "criterion": "stable disease after no more than two attempts of induction therapy",
      "label": "met"
    },
    {
      "criterion": "high-risk cytogenetics, t(4:14); t(14;16), t(14:20), deletion p17, gain in 1q",
      "label": "met"
    },
    {
      "criterion": "plasma cell leukemia in >= partial remission",
      "label": "met"
    },
    {
      "criterion": "non-quantifiable monoclonal proteins",
      "label": "met"
    },
    {
      "criterion": "Karnofsky performance status (KPS) >= 70%",
      "label": "met"
    },
    {
      "criterion": "Less than 12 months since diagnosis",
      "label": "met"
    },
    {
      "criterion": "No contraindication to the collection of a minimum of 4 x 10^6 CD34+ cells/kg by apheresis",
      "label": "met"
    },
    {
      "criterion": "Bilirubin =< 1.5 mg/dl",
      "label": "met"
    },
    {
      "criterion": "Serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < 2.5 x upper limits of normal",
      "label": "met"
    },
    {
      "criterion": "Creatinine of measured or calculated creatinine clearance of >= 50 cc/min",
      "label": "met"
    },
    {
      "criterion": "Absolute neutrophil count of > 1000/ul",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Diagnosed or treated for another malignancy within 3 years of enrollment",
      "label": "not_met"
    },
    {
      "criterion": "Known hypersensitivity to filgrastim or to Escherichia coli (E. coli) derived proteins",
      "label": "unknown"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT03100877",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}